dc.contributor.author | Ozcan, Faruk | |
dc.contributor.author | Ekenel, MELTEM | |
dc.contributor.author | Agaoglu, Fulya | |
dc.contributor.author | Basaran, Mert | |
dc.contributor.author | Sen, FATMA | |
dc.contributor.author | Darendeliler, Emin | |
dc.contributor.author | Yildiz, Ibrahim | |
dc.contributor.author | BAVBEK, Sevil | |
dc.contributor.author | Tunc, Hayri Murat | |
dc.date.accessioned | 2021-03-03T11:52:37Z | |
dc.date.available | 2021-03-03T11:52:37Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Yildiz I., Sen F., Basaran M., Ekenel M., Agaoglu F., Darendeliler E., Tunc H. M. , Ozcan F., BAVBEK S., "Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey", JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.41, sa.12, ss.1380-1387, 2011 | |
dc.identifier.issn | 0368-2811 | |
dc.identifier.other | av_2a82ff49-bcf9-43f0-9075-5e58588245ea | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/33358 | |
dc.identifier.uri | https://doi.org/10.1093/jjco/hyr151 | |
dc.description.abstract | Objective: Therapy targeted against the vascular endothelial growth factor pathway is a standard of care for patients with metastatic renal cell carcinoma. This study assessed the response rates and toxicity profiles of sunitinib on a continuous once-daily dosing regimen in Turkish patients with metastatic renal cell carcinoma. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey | |
dc.type | Makale | |
dc.relation.journal | JAPANESE JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 41 | |
dc.identifier.issue | 12 | |
dc.identifier.startpage | 1380 | |
dc.identifier.endpage | 1387 | |
dc.contributor.firstauthorID | 26335 | |